Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
76,302
Frequently Asked Questions
What is Market Cap of Novo Nordisk - Ordinary Shares - Class B?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Novo Nordisk - Ordinary Shares - Class B market cap is $248.04B.
What is the 52-week high for Novo Nordisk - Ordinary Shares - Class B?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Novo Nordisk - Ordinary Shares - Class B 52 week high is $139.99 as of September 06, 2025.
What is the 52-week low for Novo Nordisk - Ordinary Shares - Class B?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Novo Nordisk - Ordinary Shares - Class B 52 week low is $45.00 as of September 06, 2025.
What is Novo Nordisk - Ordinary Shares - Class B stock price today?
Novo Nordisk - Ordinary Shares - Class B stock price today is $54.82.
What was Novo Nordisk - Ordinary Shares - Class B stock price yesterday?
Novo Nordisk - Ordinary Shares - Class B stock price yesterday was $55.85.
What is the PE ratio of Novo Nordisk - Ordinary Shares - Class B?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Novo Nordisk - Ordinary Shares - Class B’s P/E ratio is 15.36.
What is the Price-to-Book ratio of Novo Nordisk - Ordinary Shares - Class B?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Novo Nordisk - Ordinary Shares - Class B P/B ratio is 9.3798.
What is the 50-day moving average of Novo Nordisk - Ordinary Shares - Class B?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Novo Nordisk - Ordinary Shares - Class B 50-day moving average is $59.75.
How many employess does Novo Nordisk - Ordinary Shares - Class B has?
Novo Nordisk - Ordinary Shares - Class B has 76,302 employees.
